The overall goal of the University of Iowa/Mayo Clinic Lymphoma SPORE (UI/MC SPORE)Administration Core is to stimulate research in lymphoma and to expedite the translation of discoveries intonew and better methods of prevention, detection, and treatment of lymphoma. The Administration Core hasserved well as the organizational hub of UI/MC SPORE during the initial funding period. During the next grantperiod it will continue to provide an organizational structure designed to efficiently coordinate the activities ofthe research projects, scientific cores, and developmental programs (Developmental Research Program,Career Development Program) of the UI/MC SPORE. It will also serve to enhance communication betweeninvestigators at Iowa and Mayo. The Administration Core will be responsible for coordinating the function ofthe SPORE committees including the Executive Committee and the External Advisory Committee. Dr. GeorgeWeiner will serve as Director of the Administration Core, and Dr. Thomas Witzig as Co-Director. Weiner andWitzig functioned well as a team during the initial funding period, and will continue to work collaboratively toprovide expertise in laboratory and clinical lymphoma research. They have extensive administrativeexperience and are well qualified to provide leadership and direction for the UI/MC SPORE. TheAdministration Core will support SPORE activities by: (1) providing leadership, organizational support, andfinancial management for UI/MC SPORE investigators; (2) coordinating monthly videoconferences andquarterly meetings of UI/MC SPORE investigators, and the ongoing scientific review of SPORE researchprojects and cores, and the visits of the external advisors; (3) providing the infrastructure for the selection andsupport of the best and most promising projects as outlined in SPORE guidelines; (4) providing for informationtransfer to the scientific community via professional and public means; (5) providing the structure for theestablishment and nurture of collaborations to facilitate and expand lymphoma research; (6) assuring inputfrom patient advocates and (7) fostering trainee development.
Showing the most recent 10 out of 387 publications
